Arsenic trioxide in recurrent urothelial cancer: a cancer and leukemia group B phase II trial (CALGB 99903).
      Google Scholar   
Citation:
Clin Genitourin Cancer vol 7 (3) E66-70
Year:
2009
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
Received
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
       
Primary Study
CALGB-99903
Secondary Studies:
Phases:
2
Keywords:
Aged, Aged, 80 and over, Antineoplastic Agents, Arsenicals, Female, Humans, Leukemia, Promyelocytic, Acute, Male, Middle Aged, Oxides, Recurrence, Survival Analysis, Treatment Outcome, Urinary Bladder Neoplasms, Urologic Neoplasms, Urothelium